Meet the Micropore team
Although he was was born in Trinidad, James has always considered Tees Valley in the UK, the birthplace of both his father and his grandfather, to be his true home. He is best known for his founding of Exwold Technology, a company from the region that today employs nearly 100 staff and has a turnover in excess of £8 million. Although he remains on the board of Exwold, since 2011 he has focused on mentoring startup businesses and chairing the Micropore board. James was awarded an MBE for Services to North East Businesses in the UK New Year’s honours list in 2011.
Dave has extensive experience in the field of micro encapsulation, including complex coacervation, melamine formaldehyde/urea formaldehyde, acrylate and hydrogel systems (alginates, chitosan, carrageenans, etc.).
He started his career in automotive coatings (ICI and DuPont) followed by a stint in the paper industry, where he focused exclusively on microencapsulation. He has since managed a variety of encapsulation projects for major multinational companies from initial product design, through to commercial sales. In 2012 he started an encapsulation division from scratch, for a UK based specialty chemicals company, resulting in an established pipeline of multinational projects in diverse application areas. He developed a patented technology, based on removing animal derived raw materials from the coacervation process.
Since joining the Micropore team this year Dave is excited by the potential of applying our unique technology to overcome technical challenges and provide significant improvements in the area of emulsification and encapsulation.
Tom is a veteran of the biotech and life science industries having spent the majority of his career in a variety of technical and commercial leadership roles most notably with Novozymes and Clariant, partnering with Fortune 500 companies around the word to help develop societal changing consumer products and new industrial processes. Tom’s business development activities have ranged from biological ingredients utilised in food, pharma, and agricultural applications to delivery systems in coatings and cosmetics. He’s also a frequent class and community lecturer in North Carolina’s Research Triangle area, home to over three hundred bioscience companies and three world leading research universities. When he’s not busy finding new opportunities for Micropore’s transformative technology he finds time for a round or two on the world’s most challenging golf courses.
Bruce is a chartered chemical and process engineer, and Fellow of the Institution of Chemical Engineers. He is on the Board of Directors for the UK Affiliate of the ISPE (International Society for Pharmaceutical Engineering).
He started his career in ICI’s Engineering and Strategic Technology groups, developing novel technologies for production of high value solid formulations. After that he joined Zeneca’s industrial biotechnology business and went on to lead the Manufacturing Technology group for Avecia’s biopharmaceutical contract manufacturing business. Since then he has helped innovative companies across a range of sectors to make advances in their process technologies and manufacturing operations.
Bruce’s work with the Micropore team since 2011 has seen the product range mature to give a clear route to scale up from initial bench feasibility studies to larger scale characterisation and on to robust kilotonne scale manufacture.
Since graduating from the University of Sussex with a master's in Chemistry, Alex has worked in the field of encapsulation and formulation, with a focus on complex coacervation, in which he, along with Dave Palmer, was granted a patent for a gelatine-and-animal-derived-material-free process.
Starting off at UK based specialty chemicals company as an encapsulation technician, Alex became the principal scientist for encapsulation technologies at the company, working for clients in sectors from FMCG to construction. Alex is excited to exploit the potential of Micropore’s high performance equipment in industry and explore the ever-expanding field of new applications for its patented technology.
Europe, Middle East, Asia
Americas & Canada